U.S. RESEARCH ROUNDUP-Aflac, Lincoln National, Prudential Financial

Reuters
09 Oct 2024

Oct 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aflac, Lincoln National and Prudential Financial on Wednesday.

HIGHLIGHTS

* Aflac Inc : TD Cowen initiates coverage with hold rating; price target $102

* Corebridge Financial Inc : TD Cowen initiates coverage with buy rating

* Lincoln National Corp : TD Cowen initiates coverage with hold rating

* Prudential Financial Inc : TD Cowen initiates coverage with hold rating

* Sirius XM Holdings Inc : JP Morgan resumes coverage with underweight rating

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Aflac Inc : TD Cowen initiates coverage with hold rating; price target $102

* Air Products : Mizuho raises target price to $360 from $308

* Amgen Inc : JP Morgan raises target price to $300 from $290

* Azek Company Inc : Barclays raises target price to $53 from $52

* Builders Firstsource Inc : Barclays raises target price to $211 from $182

* Corebridge Financial Inc : TD Cowen initiates coverage with buy rating

* Corebridge Financial Inc : TD Cowen initiates coverage with price target $35

* Danske Bank : HSBC cuts target price to DKK 252 from DKK 258

* Eagle Materials Inc : JP Morgan raises target price to $290 from $270

* Fortune Brands Innovations Inc : Barclays raises target price to $100 from $86

* GE Vernova Inc : JP Morgan raises target price to $285 from $240

* Gilead : JP Morgan raises target price to $100 from $95

* Globe Life Inc : TD Cowen initiates coverage with buy rating; price target $150

* Halozyme Therapeutics Inc : JP Morgan cuts target price to $54 from $57

* Kirby Corp : Stephens raises target price to $141 from $135

* Laureate Education Inc : Jefferies raises target price to $22 from $20

* Lincoln National Corp : TD Cowen initiates coverage with hold rating

* Lincoln National Corp : TD Cowen initiates coverage with price target $34

* Marathon Petroleum Corp : JP Morgan cuts target price to $171 from $172

* Martin Marietta Materials Inc : JP Morgan cuts target price to $515 from $560

* Masco Corp : Barclays raises target price to $92 from $88

* Merck & Co Inc : Truist Securities cuts target price to $132 from $143

* Metlife Inc : TD Cowen initiates coverage with buy rating; price target $97

* Myers Industries Inc : Keybanc cuts target price to $22 from $27

* Nasdaq Inc : JP Morgan raises target price to $83 from $77

* Nucor Corp : JP Morgan cuts target price to $170 from $174

* Pepsico : JP Morgan cuts target price to $183 from $185

* Primerica Inc : TD Cowen initiates coverage with buy rating; price target $314

* Prudential Financial Inc : TD Cowen initiates coverage with hold rating

* Prudential Financial Inc : TD Cowen initiates coverage with price target $130

* Reinsurance Group of America Inc : TD Cowen initiates coverage with hold rating

* Reinsurance Group of America Inc : TD Cowen initiates coverage with PT $235

* Sage Therapeutics Inc : Oppenheimer cuts target price to $9 from $10

* Sirius XM Holdings Inc : JP Morgan resumes coverage with underweight rating

* Sirius XM Holdings Inc : JP Morgan resumes coverage with target price $20

* Steel Dynamics Inc : JP Morgan cuts target price to $129 from $131

* Summit Materials Inc : JP Morgan cuts target price to $43 from $47

* TPG Inc : JP Morgan raises target price to $56 from $49

* US Physical Therapy Inc : Jefferies cuts target price to $100 from $122.5

* Vulcan Materials Co : JP Morgan cuts target price to $245 from $250

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10